Hackensack University Medical Center
New York, NY, United States
Dr. Sarah Bayefsky is an adult and pediatric rheumatologist at Hackensack Meridian Health in Hackensack, NJ. Her interests include rheumatologic care for patients of all ages, transition from pediatric to adult care for adolescents and young adults, curriculum design and delivery, and qualitative medical education research. She serves as the Pediatric Rheumatology Fellowship Associate Program Director at Hackensack University Medical Center, the course director of Patient Presentation Problem-Based Learning Curriculum (PPPC) at Hackensack Meridian School of Medicine, a member of the Committee on Education and Annual Meeting Planning Committee at the American College of Rheumatology, and a co-leader of the Childhood Arthritis and Rheumatology Research Alliance Medical Education Workgroup.
16S27: Eyes on the Prize: Current and Emerging Therapies for Non-Infectious Uveitis
Saturday, November 16, 2024
1:00 PM – 2:00 PM Eastern Time
No financial relationships with ineligible companies to disclose
17S06: Navigating the CNO/SAPHO Spectrum: From Symptoms to Solutions
Sunday, November 17, 2024
9:00 AM – 10:00 AM Eastern Time
No financial relationships with ineligible companies to disclose
17S27: Giving and Receiving Feedback: How to Avoid Common Traps
Sunday, November 17, 2024
1:00 PM – 2:00 PM Eastern Time
No financial relationships with ineligible companies to disclose
Lost in Transition: Practical Pearls for Partnering with Young Adults
Sunday, November 17, 2024
3:40 PM – 4:00 PM Eastern Time
No financial relationships with ineligible companies to disclose
Sunday, November 17, 2024
3:00 PM – 3:15 PM Eastern Time
No financial relationships with ineligible companies to disclose
18M02: From Tiny Steps to Adult Strides: Mastering the Transition
Monday, November 18, 2024
9:00 AM – 10:00 AM Eastern Time
No financial relationships with ineligible companies to disclose
Monday, November 18, 2024
4:30 PM – 5:30 PM Eastern Time
No financial relationships with ineligible companies to disclose